News
Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
10+ hour, 23+ min ago (220+ words) RINGSIDE Key Clinical Data Presented at 2026 ASCO Meeting As previously reported, the RINGSIDE trial met its primary endpoint and all key secondary endpoints. Varegacestat demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) vs. placebo, with an…...
Tempus Introduces "Preview: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
10+ hour, 23+ min ago (494+ words) The National Law Review Tempus Introduces "Preview: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced…...
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
10+ hour, 23+ min ago (431+ words) Tempus Launches the PRECISION Challenge, a National Program Openi The National Law Review Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community Inaugural program provides unprecedented access to Tempus" library of…...
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
10+ hour, 23+ min ago (486+ words) Promising Data Further Support Continued Expansion of Ivonescimab Clinical Development in m CRC Overall Study Population Achieved ORR of 70. 8% and DCR of 100. 0%; Responses Consistent Across Ivonescimab Dose Levels Combined with Chemotherapy Acceptable and Manageable Safety Profile for Ivonescimab Regimen; No…...
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
10+ hour, 23+ min ago (556+ words) For more information on the TALAPRO-3 trial (NCT04821622), go to www. clinicaltrials. gov. TALZENNA is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair. Preclinical studies have demonstrated that TALZENNA blocks PARP enzyme activity…...
Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5 T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting
4+ hour, 21+ min ago (605+ words) Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK0 The National Law Review Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5 T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting Robust enrollment of 173 patients across dose escalation and…...
Massive Bio Announces Next-Generation Reticulum Nexus" Product Suite at ASCO 2026
10+ hour, 23+ min ago (612+ words) The new suite brings together Patient Connect, Trial Relay, Nexus Pulse, Sentinel Agents, Dr Arturo AI, and Phoebe AI into a real-time multi-agent ecosystem for patients, physicians, sites, sponsors, advocacy organizations, and health systems. "Most oncology AI tells you what…...
Incyte's Pivotal front MIND Trial Showed Tafasitamab (Monjuvi/Minjuvi) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL
10+ hour, 23+ min ago (528+ words) The results build on previously reported topline data indicating the trial met its primary endpoint of progression-free survival (PFS) by investigator assessment. The data demonstrate that Tafa-Len-R-CHOP resulted in a statistically significant and clinically meaningful improvement in PFS, with a…...
Synergy Rehab Continues Expanding Multidisciplinary Rehabilitation Across British Columbia With Patient-First Care
11+ hour, 23+ min ago (446+ words) The Directors of Synergy Rehab said, "Our vision for Synergy Rehab was always centered around making rehabilitation more convenient, collaborative, and effective for patients. By bringing multiple rehabilitation services together, practitioners can collaborate closely and provide more comprehensive care." The…...
Author Ani Retak Unveils 'Breathe Wisely': A Self-Help Guide on Breath and Nervous System Awareness
11+ hour, 23+ min ago (212+ words) Breathe Wisely Book Cover With growing interest in mindfulness, stress management, and holistic wellness, Breathe Wisely presents a grounded approach that focuses on one of the body's most constant functions. The book explains how breathing patterns shape daily experiences and…...